Document is current

Article History

Received: 30 June 2022

Accepted: 2 September 2022

First Online: 20 September 2022

Declarations

:

: All procedures have been approved by the City of Philadelphia IRB and all ethical guidelines will be followed. Modifications to study procedures will be submitted to the IRB in accordance with their guidelines. All research participants will provide written consent prior to participating; trained study staff will carry out consent procedures. Any significant changes to the study protocol that impact provider participation will be communicated to those participants. Any solicited or spontaneously reported adverse events will be reported to the IRB. This report was prepared in accordance with Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 guidelines [].

: Not applicable

: The authors have read the journal's policy and the authors of this study have the following competing interests to declare: David C. Atkins, Michael J. Tanana, Zac E. Imel, and Shrikanth Narayanan are co-founders with equity stake in a technology company, Lyssn.io, focused on tools to support training, supervision, and quality assurance in psychotherapy. Torrey Creed is an advisor with an equity stake in Lyssn.io. The remaining authors report no conflicts of interest. Lyssn intends to commercialize the LyssnCBT software, which is the focus of the current article.